Skip to content
Journal article

Gastrointestinal stromal tumors: The histology report

Dei Tos A, Laurino L, Bearzi I, Messerini L, Farinati F...(+5 more)

Digestive and Liver Disease, vol. 43, issue SUPPL. 4 (2011)

  • 18

    Readers

    Mendeley users who have this article in their library.
  • 19

    Citations

    Citations of this article.
  • 1.2k

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Gastrointestinal stromal tumors (GISTs) represent a mesenchymal neoplasm occurring primarily in the gastrointestinal tract, and showing differentiation toward the interstitial cell of Cajal. Its incidence is approximately 15 case/100,000/year. Stomach and small bowel are the most frequently affected anatomic sites. GIST represents a morphological, immunophenotypical and molecular distinct entity, the recognition of which has profound therapeutic implications. In fact, they have shown an exquisite sensitivity to treatment with the tyrosine kinase inhibitor imatinib. Diagnosis relies upon morphology along with immunodetection of KIT and/or DOG1. When dealing with KIT negative cases, molecular analysis of KIT/PDGFRA genes may help in confirming diagnosis. Molecular evaluation of both genes are in any case recommended as mutational status provides key predictive information. Pathologists also play a key role in providing an estimation of the risk of biological aggressiveness, which is currently based on anatomic location of the tumor, size, and mitotic activity. ?? 2011 Editrice Gastroenterologica Italiana S.r.l.

Author-supplied keywords

  • GIPAD report
  • GIST
  • Imatinib
  • Sarcoma

Find this document

Get full text

Cite this document

Choose a citation style from the tabs below